[Joint detection of serum NLR, PSA and MMP26 in differentiating prostate cancer from benign prostatic hyperplasia].
The joint detection of serum NLR, PSA and MMP26 has significant application value in the differentiation of PCa and BPH, which is expected to become an effective tool for early screening and diagnosis of PCa.
Authors
- Guang-Bo Fu
- Qiang Li (ORCID: https://orcid.org/0009-0008-9435-2993)
- Yijin Wang (ORCID: https://orcid.org/0000-0002-2340-0037)
Institutions
- Xuzhou Medical College (CN)
- Huaian First People’s Hospital (CN)
- Second People’s Hospital of Huai’an (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-01
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article